Becton, Dickinson & Co. (BDX)
168.64
-2.85
(-1.66%)
USD |
NYSE |
Mar 05, 14:16
Becton, Dickinson Cash from Investing (Quarterly) : -183.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Baxter International, Inc. | -198.00M |
| Abbott Laboratories | -913.00M |
| Boston Scientific Corp. | -512.00M |
| West Pharmaceutical Services, Inc. | -76.10M |
| Integra LifeSciences Holdings Corp. | -34.91M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 657.00M |
| Cash from Financing (Quarterly) | -302.00M |
| Free Cash Flow | 2.631B |
| Free Cash Flow Per Share (Quarterly) | 1.921 |
| Free Cash Flow to Equity (Quarterly) | 1.03B |
| Free Cash Flow to Firm (Quarterly) | 697.72M |
| Free Cash Flow Yield | 5.44% |